Marc E Uknis
Overview
Explore the profile of Marc E Uknis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
185
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Berger M, Liu M, Uknis M, Koulmanda M
Am J Transplant
. 2018 Apr;
18(7):1589-1595.
PMID: 29607607
Limited availability of donor organs and risk of ischemia-reperfusion injury (IRI) seriously restrict organ transplantation. Therapeutics that can prevent or reduce IRI could potentially increase the number of transplants by...
2.
Riedl M, Lumry W, Li H, Craig T, Fitts D, Kalfus I, et al.
Am J Rhinol Allergy
. 2013 Nov;
27(6):517-21.
PMID: 24274230
Background: Laryngeal edema is a life-threatening manifestation of hereditary angioedema (HAE), an autosomal-dominant disorder caused by quantitative or functional C1 esterase inhibitor (C1 INH) deficiency. The preparation of nanofiltered C1...
3.
Baker J, Craig T, Riedl M, Banerji A, Fitts D, Kalfus I, et al.
Allergy Asthma Proc
. 2013 Mar;
34(2):162-9.
PMID: 23484892
Data are limited on hereditary angioedema (HAE) in pregnant women and the safety and efficacy of therapies for treatment and prevention of HAE attacks during pregnancy. Prospective studies are unlikely...
4.
Lumry W, Manning M, Hurewitz D, Davis-Lorton M, Fitts D, Kalfus I, et al.
J Pediatr
. 2013 Jan;
162(5):1017-22.e1-2.
PMID: 23312695
Objectives: To evaluate the use of Cinryze (nanofiltered C1-esterase inhibitor [C1 INH-nf]) for the acute management and prevention of hereditary angioedema attacks in the subgroup of children and adolescents who...
5.
Grant J, White M, Li H, Fitts D, Kalfus I, Uknis M, et al.
Allergy Asthma Proc
. 2012 Aug;
33(4):348-53.
PMID: 22856635
Patients with hereditary angioedema (HAE) may have attacks triggered by dental, medical, or surgical procedures. This analysis evaluated the efficacy and safety of preprocedural administration of nanofiltered C1 esterase inhibitor...
6.
Pavlakis M, Khwaja K, Mandelbrot D, Tang H, Whiting J, Lorber M, et al.
Transplantation
. 2010 Mar;
89(11):1347-53.
PMID: 20216481
Background: The reasons for kidney allograft failure subsequent to pancreas after kidney (PAK) are multifactorial; therefore, we examined these factors to identify a meaningful risk assessment that could assist in...
7.
Bodonyi-Kovacs G, Putheti P, Marino M, Avihingsanon Y, Uknis M, Monaco A, et al.
Hum Immunol
. 2010 Feb;
71(5):451-5.
PMID: 20156509
We have previously demonstrated that biomarkers of inflammation and immune activity detected within intraoperative renal transplant allograft biopsies are linked to adverse short-term post-transplantation clinical outcomes. Now we provide a...
8.
Fishman J, Emery V, Freeman R, Pascual M, Rostaing L, Schlitt H, et al.
Clin Transplant
. 2007 Apr;
21(2):149-58.
PMID: 17425738
Background: Cytomegalovirus (CMV) infection of solid organ transplant (SOT) recipients causes both ''direct'' and ''indirect'' effects including allograft rejection, decreased graft and patient survival, and predisposition to opportunistic infections and...
9.
Weng F, Patel A, Wanchoo R, Brahmbhatt Y, Ribeiro K, Uknis M, et al.
Transplantation
. 2007 Feb;
83(3):290-6.
PMID: 17297403
Background: The optimal regimen for prophylaxis of cytomegalovirus (CMV) disease after kidney and/or pancreas transplantation remains unclear. We compared the effectiveness of three months of oral ganciclovir (3 g/day) versus...
10.
Bradley S, Rastellini C, da Costa M, Kowalik T, Bloomenthal A, Brown M, et al.
Pancreas
. 2005 Nov;
31(4):373-9.
PMID: 16258373
Objectives: RNA interference as mediated by short-interfering RNA (siRNA) offers a nonviral means to silence genes in tissue; however, few data exist about gene therapy using siRNA in pancreas tissue....